This small article was in our local news yesterday. There was no other links or info:
An experimental drug is showing promise in the treatment of migraines.
Nearly 17-hundred patients were involved in the phase 3 study.
Among those who were given the drug Ubrogepant, nearly 22% were free of migraine pain symptoms two hours later.
That is compared to the 14% who were on the placebo.
An FDA decision on approval is expected next month.
Copyright 2019 NBC News. All rights reserved.